http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw#head http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw#assertion http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw#provenance http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw#publicationInfo http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw#assertion http://bio2rdf.org/drugbank:DB06228 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB06228_DB06695 http://bio2rdf.org/drugbank:DB06695 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB06228_DB06695 http://bio2rdf.org/drugbank_resource:DB06228_DB06695 http://purl.org/dc/terms/identifier drugbank_resource:DB06228_DB06695 http://bio2rdf.org/drugbank_resource:DB06228_DB06695 http://purl.org/dc/terms/title DDI between Rivaroxaban and Dabigatran etexilate - Using additional anticoagulants such as dabigatran can increase the anticoagulant effect of rivaroxaban. Avoid concurrent use of rivaroxaban with other anticoagulants whenever possible, other than during transition periods, due to the possible increased for bleeding. http://bio2rdf.org/drugbank_resource:DB06228_DB06695 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB06228_DB06695 http://www.w3.org/2000/01/rdf-schema#label DDI between Rivaroxaban and Dabigatran etexilate - Using additional anticoagulants such as dabigatran can increase the anticoagulant effect of rivaroxaban. Avoid concurrent use of rivaroxaban with other anticoagulants whenever possible, other than during transition periods, due to the possible increased for bleeding. [drugbank_resource:DB06228_DB06695] http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw#provenance http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw#publicationInfo http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw#signature.MCwCFBIrowYUVmhD http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw#signature.MCwCFBIrowYUVmhD http://purl.org/nanopub/x/hasSignature MCwCFBIrowYUVmhDuup9ZtXYtPMtNx5fAhQbvaPzBNGBNNnkxtnuynNc41lLeQ== http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw#signature.MCwCFBIrowYUVmhD http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw http://purl.org/dc/terms/created 2018-03-30T11:12:55.263+02:00 http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw#signature.MCwCFBIrowYUVmhD http://bio2rdf.org/drugbank_resource:DB06228_DB06695_nanopub.RAFGYDU49tdGSlFeqs_4omZf5CoORgM1erJDzb6VsY2Jw http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234